Autologous platelet-rich plasma for treating surgical wounds
Por:
Martinez-Zapata M.J., Martí-Carvajal A.J., Solà I., Bellmunt-Montoya S., Cid J., Urrútia G.
Publicada:
1 ene 2013
Resumen:
This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the efficacy and safety of autologous PRP compared to placebo, standard treatment, and alternative treatments such as plasma poor in platelets, laser (common in plastic surgery) or biomaterials (e.g. acellular xenogeneic dermal matrix or Keratinocyte suspension; Appendix 1), for surgical wounds. © 2013 The Cochrane Collaboration.
Filiaciones:
Martinez-Zapata M.J.:
CIBER Epidemiología y Salud Pública (CIBERESP), Spain, Iberoamerican Cochrane Centre. Universitat Autònoma de Barcelona, Institute of Biomedical Research Sant Pau (IIB Sant Pau), Barcelona, Sant Antoni M. Claret 171, Casa de Convalescència, Barcelona, Catalonia, 08041, Spain
Martí-Carvajal A.J.:
Facultad de Ciencias de la Salud Eugenio Espejo, Centro Cochrane Ecuador, Universidad Tecnológica Equinoccial, Quito, Ecuador
Solà I.:
CIBER Epidemiología y Salud Pública (CIBERESP), Spain, Iberoamerican Cochrane Centre, Institute of Biomedical Research (IIB Sant Pau), Sant Antoni Maria Claret 171-Edifici Casa Convalescencia, Barcelona, Catalunya, 08041, Spain
Bellmunt-Montoya S.:
Hospital de la Santa Creu i Sant Pau, IBB Sant Pau, Angiology, Vascular and Endovascular Surgery, Sant Quinti No. 89, Barcelona, 08041, Spain
Cid J.:
Hospital Universitari Joan XXIII, Hematology, C/. Dr. Mallafré Guasch, 4, Tarragona, 43007, Spain
Urrútia G.:
CIBER Epidemiología y Salud Pública (CIBERESP), Spain, Iberoamerican Cochrane Centre -IIB Sant Pau, c/ Sant Antoni Maria Claret 171, Barcelona, 08041, Spain
|